ID

34355

Description

Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02024334

Link

https://clinicaltrials.gov/show/NCT02024334

Keywords

  1. 1/16/19 1/16/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 16, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Juvenile Idiopathic Arthritis NCT02024334

Eligibility Juvenile Idiopathic Arthritis NCT02024334

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
jia based on acr criteria
Description

ID.1

Data type

boolean

age between 2- 19 y
Description

ID.2

Data type

boolean

polyarticular, oligoarticular(> or = 3 active joints) or extended oligoarticular subtypes
Description

ID.3

Data type

boolean

resistance to conventional treatment
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy
Description

ID.5

Data type

boolean

malignancy
Description

ID.6

Data type

boolean

severe active infection
Description

ID.7

Data type

boolean

other rheumatic diseases or overlap
Description

ID.8

Data type

boolean

alt(alanine transaminase) or bilirubin > 3 folds
Description

ID.9

Data type

boolean

ivig (intravenous immunoglobulin) treatment during last 2 weeks
Description

ID.10

Data type

boolean

biologic agents during last 3 months
Description

ID.11

Data type

boolean

Similar models

Eligibility Juvenile Idiopathic Arthritis NCT02024334

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
jia based on acr criteria
boolean
ID.2
Item
age between 2- 19 y
boolean
ID.3
Item
polyarticular, oligoarticular(> or = 3 active joints) or extended oligoarticular subtypes
boolean
ID.4
Item
resistance to conventional treatment
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
pregnancy
boolean
ID.6
Item
malignancy
boolean
ID.7
Item
severe active infection
boolean
ID.8
Item
other rheumatic diseases or overlap
boolean
ID.9
Item
alt(alanine transaminase) or bilirubin > 3 folds
boolean
ID.10
Item
ivig (intravenous immunoglobulin) treatment during last 2 weeks
boolean
ID.11
Item
biologic agents during last 3 months
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial